Loading...
Loading...
The most validated longevity drug in history — low-dose mTOR inhibition for healthspan extension
Availability varies by city. Gabriel can help find a practitioner or adjacent option.

During the visit
Comprehensive baseline labs: CBC, CMP, lipid panel, fasting insulin, inflammatory markers, immune panel
Typical protocol: 3-6mg rapamycin taken once weekly (pulsed dosing)
Regular monitoring every 3-6 months: lipids, blood glucose, CBC, immune markers
Some patients notice improved skin quality and reduced joint pain within weeks
Duration
Ongoing (weekly dosing)
Starting at
$50
Practitioner access
Ask Gabriel
Category
Longevity
About this treatment
Rapamycin (sirolimus) is the single most validated longevity compound in the history of aging research. Originally developed as an immunosuppressant for organ transplant patients, low-dose rapamycin has been shown to extend lifespan in every organism tested — from yeast and worms to mice and dogs. The Interventions Testing Program (ITP), the gold standard of aging research funded by the NIH, has repeatedly confirmed rapamycin's lifespan-extending effects.
Rapamycin works by inhibiting mTOR (mechanistic target of rapamycin), a cellular nutrient-sensing pathway that promotes growth when active. By periodically dampening mTOR signaling, rapamycin triggers autophagy (cellular cleanup), reduces inflammation, improves immune function (paradoxically, at low doses), enhances mitochondrial function, and slows cellular aging.
Longevity physicians prescribe low-dose rapamycin off-label (typically 3-6mg once weekly, much lower than transplant doses) as part of comprehensive longevity protocols. The Dog Aging Project is currently studying rapamycin in thousands of pet dogs, providing real-world mammalian data that will further validate its use.
Visit flow
Comprehensive baseline labs: CBC, CMP, lipid panel, fasting insulin, inflammatory markers, immune panel
Typical protocol: 3-6mg rapamycin taken once weekly (pulsed dosing)
Regular monitoring every 3-6 months: lipids, blood glucose, CBC, immune markers
Some patients notice improved skin quality and reduced joint pain within weeks
Side effects at low doses are generally mild: occasional mouth sores, mild lipid changes
Many longevity physicians combine with metformin, NAD+ precursors, and senolytics
Best for
Adults 40+ pursuing evidence-based longevity protocols
Anyone interested in the most scientifically validated anti-aging intervention
Patients with physician oversight who want to add mTOR modulation to their protocol
People already on longevity stacks (NAD+, metformin, senolytics) looking for the next level
Key outcomes
Most validated longevity drug — extends lifespan in every organism tested
Activates autophagy (cellular recycling and cleanup)
Reduces chronic inflammation and improves immune function at low doses
Enhances mitochondrial function and energy production
Gabriel intelligence
Treatment fit
Root-cause context before you book
Gabriel can help decide whether rapamycin (mtor modulation) fits your symptoms, labs, and recovery goals before you spend money on a session.
Protocol pairing
Connect sessions to a real plan
Gabriel can pair this with diagnostics, supplements, peptides, and follow-up cadence so it fits into a real protocol instead of sitting in isolation.
Practitioner match
Find the right clinic, not just the nearest one
Gabriel uses trust, treatment fit, and modality overlap to surface practitioners who are more likely to be a strong match for this exact treatment path.
Evidence & safety
Strongest preclinical evidence of any longevity compound. Human data from transplant populations (much higher doses) and growing off-label longevity use. Low-dose pulsed protocols have favorable safety profiles but require regular monitoring. Prescription required. Must be supervised by a physician experienced in longevity medicine.
Related treatments
Use these when you want adjacent options in the same category before deciding what to book.
Tell Gabriel what you are dealing with and what you have already tried. You will get a more useful answer than a generic treatment directory can give.